Conversion of Danger Signals into Cytokine Signals by Hematopoietic Stem and Progenitor Cells for Regulation of Stress-Induced Hematopoiesis  by Zhao, Jimmy L. et al.
Cell Stem Cell
ArticleConversion of Danger Signals into Cytokine Signals
by Hematopoietic Stem and Progenitor Cells
for Regulation of Stress-Induced Hematopoiesis
Jimmy L. Zhao,1,5,* Chao Ma,2,5 Ryan M. O’Connell,4 Arnav Mehta,1 Race DiLoreto,2 James R. Heath,2,3,*
and David Baltimore1,*
1Division of Biology and Biological Engineering, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
2NanoSystems Biology Cancer Center, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
3Kavli Nanoscience Institute, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
4Department of Pathology, University of Utah, 15 North Medical Drive East, Salt Lake City, UT 84112, USA
5These authors contribute equally to this work
*Correspondence: jzhao@caltech.edu (J.L.Z.), heath@caltech.edu (J.R.H.), baltimo@caltech.edu (D.B.)
http://dx.doi.org/10.1016/j.stem.2014.01.007SUMMARY
During an infection, the body increases the output
of mature immune cells in order to fight off the path-
ogen. Despite convincing evidence that hemato-
poietic stem and progenitor cells (HSPCs) can sense
pathogens directly, how this contributes to hemato-
poietic cell output remains unknown. Here, we have
combined mouse models with a single-cell prote-
omics platform to show that, in response to Toll-
like receptor stimulation, short-term HSCs and
multipotent progenitor cells produce copious
amounts of diverse cytokines through nuclear factor
kB (NF-kB) signaling. Interestingly, the cytokine pro-
duction ability of HSPCs trumps mature immune
cells in both magnitude and breadth. Among cyto-
kines produced by HSPCs, IL-6 is a particularly
important regulator of myeloid differentiation and
HSPC proliferation in a paracrine manner and in
mediating rapid myeloid cell recovery during neutro-
penia. This study has uncovered an important prop-
erty of HSPCs that enables them to convert danger
signals into versatile cytokine signals for the regula-
tion of stress hematopoiesis.
INTRODUCTION
Immune cells of the myeloid lineage are often considered the
first responders of host defense against bacterial infection;
meanwhile, hematopoietic stem and progenitor cells (HSPCs)
may respond in a delayed fashion to ensure sufficient production
of myeloid cells consumed during an infection. The response by
HSPCs was originally thought to be of a passive response to the
depletion of downstream immune cells, but more recent evi-
dence suggests that HSPCs may participate directly by sensing
systemically elevated cytokines through cytokine receptors and
bacterial and viral components through Toll-like receptors (TLRs)
(King and Goodell, 2011; Nagai et al., 2006).It is well known that immune cells are potent cytokine pro-
ducers upon encountering bacteria and viruses. When cytokines
produced by immune cells and nonhematopoietic tissues accu-
mulate to sufficient quantity, they circulate back to the bone
marrow (BM) niche via blood circulation to activate HSPCs.
Numerous cytokines, including IL-6, TNF-a, IFN-a, IFN-g, TGF-
b, and M-CSF, with the ability to regulate proliferation and differ-
entiation of HSPCs have been identified (Baldridge et al., 2010,
2011; Challen et al., 2010; Essers et al., 2009; Maeda et al.,
2009; Mossadegh-Keller et al., 2013; Pronk et al., 2011). On
the other hand, it is clear now that HSPCs can also respond
to TLR stimulation directly, leading to accelerated myeloid cell
production in vitro (Nagai et al., 2006) and most likely in vivo as
well (Megı´as et al., 2012). However, it remains unclear how direct
pathogen sensing by HSPCs translates into signals directing
myeloid differentiation under the stressed conditions. Conven-
tional wisdom would suggest that TLR signaling activates line-
age-specific transcriptional factors that can directly regulate
differentiation within HSPCs. Currently, little is known about
what transcription factors downstream of TLR activation might
mediate this process. An alternative, but not mutually exclusive,
hypothesis is that TLR stimulation activates a general proinflam-
matory program within HSPCs in order to induce cytokine pro-
duction, which can act in an autocrine or paracrine manner to
regulate differentiation.
In this study, we have combined extensive mouse genetics
and a microfluidic single-cell proteomics platform to show that
HSPCs can directly respond to bacterial components via the
TLR/necrosis nuclear factor kB (NF-kB) axis, and, in response,
HSPCs, specifically short-term HSCs (ST-HSCs) and multipo-
tent progenitor cells (MPPs), produce copious amounts of cyto-
kines. In addition, single-cell analysis shows that HSPCs contain
heterogeneous subsets based on their different cytokine pro-
duction profiles. The cytokine production ability of HSPCs is
shown to be regulated byNF-kBactivity, given that p50-deficient
HSPCs have significantly attenuated cytokine production,
whereas miR-146a-deficient HSPCs display significantly
enhanced cytokine production. Interestingly, HSPCs are signifi-
cantly more potent cytokine producers in both breadth and
quantity than the conventional known cytokine producers of
the immune system, such as myeloid cells and lymphocytes.Cell Stem Cell 14, 445–459, April 3, 2014 ª2014 Elsevier Inc. 445
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HSPCs Regulate Myelopoiesis via CytokinesFurthermore, we have shown that HSPCs possess TLRs, func-
tional NF-kB signaling, and cytokine receptors—an entire
cascade of molecules necessary for translating danger signals
into cytokine signals. Lastly, we have demonstrated the func-
tional significance of HSPC-produced cytokines, especially IL-
6, in promoting myelopoiesis in vitro and in vivo in neutropenic
mice after chemotherapeutic treatment or BM transplant. We
believe that this represents a previously underappreciated
mechanism by which HSPCs convert danger signals encoun-
tered during an infection into a range of versatile cytokine signals
in order to ensure efficient stress-induced hematopoiesis. This
circumvents both the delay associated with having to wait for
systemic cytokine accumulation and the need to ‘‘reinvent’’ the
molecular circuitry within HSPCs in order to convert TLR activa-
tion into specific differentiation signals.
RESULTS
Heterogeneity in Cytokine Production Profile among
Purified HSPCs
To test whether any of the HSPC populations have the capability
of cytokine production, we adapted a high-throughput, micro-
fluidic-based technology to quantify a panel of up to 15 secreted
proteins at the single-cell level (Ma et al., 2011). HSPCs are rare
cells in BM, with LSK cells (defined as LinSca1+cKit+), a mixed
population of long-term HSCs (LT-HSCs), ST-HSCs, MPPs, and
lymphoid-biased MPPs (LMPPs) accounting for less than 1%
and LT-HSCs accounting for less than 0.1% of the total nucle-
ated BM cells. This microfluidic platform allowed us to simulta-
neously measure a large number of secreted proteins at the
single-cell level from thousands of phenotypically defined cells.
After sorting LSK cells and LT-HSCs (defined as LSK CD150+
CD48) with stringent gating criteria and reanalyzing the sorted
fraction for purity (Figure S1A available online), we loaded the
cells onto chips containing several thousand microchambers.
After 12 hr of incubation with culture medium containing
either lipopolysaccharide (LPS), a TLR-4 ligand, alone or with
Pam3CSK4, a TLR-2 ligand, secreted proteins were quantified
by an ELISA-based method (Ma et al., 2011). At this time, nearly
all LSK cells remained undifferentiated by fluorescence-
activated cell sorting (FACS) analysis (Figure S2). Interestingly,Figure 1. Single-Cell Analysis of Cytokine Production by WT HSPCs in
(A–D) Data from single-cell cytokine chip analysis. The four cell groups analyzed a
LPS, and LSK cells with LPS and Pam3CSK4 stimulation for 12 hr. LSK is define
(A) Polyfunctionality and population-level statistics of the cell types analyzed. The
cell type studied. Different colors represent cells producing different number of c
cell type shows the total percentage of cells secreting detectable amount of any
(B) Comparison of HSCs and LSK cells by individual cytokine. Each plot is compo
four cell groups arranged from left to right are HSCs under LPS and Pam3CSK
stimulation only (light blue), and LSK cells with LPS and Pam3CSK4 stimulation (d
cells identified by the gate (the dotted line), and the bars represent the mean intens
dotted line).
(C) A summary heat map showing the percentage of HSCs and LSK cells that se
(D) Clustering analysis of WT LSK cells under LPS and Pam3CSK4 stimulation wi
two-way hierarchical clustering that groups similar proteins and cells together. Th
represents an individual cytokine, and each column represents an individual cell.
cytokine secretion from purple (undetectable) to yellow (intermediate) to red (ma
(1 to 4) are identified. Each cell group is replotted onto the 2D principal component
of the information from the data. The arrows indicate the directions of the two cy
See also Figures S1–S3.although very few stimulated LT-HSCs produced cytokines, a
significant fraction of LSK cells produced a wide range of cyto-
kines upon TLR stimulation (Figures 1A–1C and S3). Cytokine
production by LSK cells was stimulation dependent, given that
few LSK cells had detectable secretion in the absence of stimu-
lation. Furthermore, although LPS alone was sufficient to stimu-
late 12.9% of LSK cells to produce cytokines, a combination
of LPS and Pam3CSK4 boosted the percentage to 37.9%, and
many more cells secreted multiple cytokines, suggesting an ad-
ditive effect of simultaneously stimulating multiple TLRs (Figures
1A–1C). Among the 12 cytokines studied, IL-6 was the most
prominently induced and was secreted by 21.9% of LPS and
Pam3CSK4-stimulated LSK cells, whereas the production of
the other cytokines ranged from 7%–15% (Figures 1B and 1C).
Among the 12 cytokines in the panel, most are produced by
multiple immune cell types. However, some cytokines, such as
IL-2, IL-4, IL-17, and IFN-g aremainly produced by lymphocytes,
whereas IL-1b, IL-6, IL-12, TNF-a, and GM-CSF are more abun-
dantly produced by cells of the myeloid lineage (Janeway et al.,
2001). Interestingly, when unsupervised clustering analysis was
performed on LSK cells, it identified two main cytokine clusters:
a cytokine cluster (group i) including IL-6, TNF-a, IL-12, and GM-
CSF that resembles the production profile of myeloid cells, and a
cytokine cluster (group ii) including IL-2, IL-4, IL-10, and IFN-g
that resembles the production profile of lymphocytes (Figure 1D).
LSK cells were divided into multiple functional subsets differing
in their ability to produce group i and group ii cytokines, ranging
from nonproducers (Figure 1D, subset 1), group i producers (Fig-
ure 1D, subset 2), group ii producers (Figure 1D, subset 3), to
superproducers of all cytokines (Figure 1D, subset 4). When
the cells from the four subsets were plotted onto the 2D principal
component plane with the two vectors representing the two
cytokine groups, subset 2 cells fell into the group i direction,
and subset 3 cells fell into the group ii direction, whereas subset
4 cells fell between the two vector directions (Figure 1D, bottom),
demonstrating once again the differential cytokine secretion
profiles among LSK cells.
LSK cells represent a heterogeneous population comprising
LT-HSCs, ST-HSCs, MPPs, and LMPPs. They represent cells
along a differentiation tree with successive loss of self-renewal
ability while still retaining the full potential to replenish most, ifResponse to TLR Stimulation
re HSCs with LPS and Pam3CSK4, LSK cells with medium only, LSK cells with
d by LinSca1+cKit+, and HSC is defined by LSK CD150+CD48.
percentage of cells secreting different number of cytokines is shown for each
ytokines from 1 to 12 (labeled with different colors); the number on top of each
of the 12 cytokines.
sed of several thousand individual dots from several thousand single cells. The
4 stimulation (black), LSK cells with no stimulation (cyan), LSK cells with LPS
ark blue). The numbers on top represent the percentage of cytokine-producing
ity of only the cytokine-producing cells (average intensity of the cells above the
crete any individual cytokine under different stimulations.
th results presented as heat maps and scatter plots. The data are analyzed by
e grouping is shown by the tree structure for both proteins and cells. Each row
The result is presented by a heat map with colors representing the amount of
ximum). Two major groups of proteins (i and ii) and four main groups of cells
plane. This reduced space is the one that can explain the largest fraction (65%)
tokine functional groups aligned to the x and y axes.
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et al., 2006). Next, we asked whether the LSK heterogeneity
based on cytokine production profile correlates with known
HSPC subsets. To study this, we separately purified LT-HSCs
(LSK Flt3CD34), ST-HSCs (LSK Flt3CD34+), MPPs (LSK
Flt3intCD34+), and LMPPs (LSK Flt3hiCD34+) from the LSK pop-
ulation and analyzed their cytokine secretion with the single-
cell microfluidic chips (Figures 2 and S4). We confirmed that
LT-HSCs lacked cytokine production with the use of a set of
stem cell markers different from those used in Figure 1 because
of controversy over what set of markers best defines HSCs. In
comparison, ST-HSCs and MPPs were potent cytokine pro-
ducers, whereas more differentiated LMPPs produced rather
modest levels of cytokines (Figures 2A–2C and S4). Furthermore,
similar to unfractionated LSK cells, ST-HSCs and MPPs re-
mained heterogeneous in terms of cytokine production profile
(Figure S4A). These results were succinctly summarized with
principal component analysis in order to reduce the 12-dimen-
tional cytokine intensity data set from six different BM subsets
down to two principal components (Figures 2D and 2E). Principal
component 1 (PC1) represents a measure of the overall cytokine
secretion ability of a cell and is positively correlated with the in-
tensity of each of the 12 cytokines (Figure S4C). When LT-HSCs,
ST-HSCs, MPPs, and LMPPs along with unfractionated LSK
cells and total BM were compared along PC1, a majority of LT-
HSCs and LMPPs were clustered at the lower end of PC1, indi-
cating very low overall cytokine secretions, whereas ST-HSCs
and MPPs contained a large fraction of high cytokine secretors
(Figure 2D). Principal component 2 (PC2) is a measure of cyto-
kine secretion bias and is positively correlated with lymphoid
cytokines (Figure S4D) but negatively correlated with myeloid
cytokines (Figure S4E). When the six cell types were compared
along PC2, LSK cells, ST-HSCs, and MPPs were heterogeneous
with relatively even distribution across PC2, indicating that they
contained a mixture of nonproducers, myeloid cytokine-biased,
lymphoid cytokine-biased, and balanced producers. In compar-
ison, unfractionated BM cells showed moderate myeloid-cyto-
kine bias, and LMPPs showed moderate lymphoid-cytokine
bias (Figure 2E). It is known that HSCs defined by current best
cell-surface markers represent a heterogeneous population
with biased myeloid or lymphoid lineage potential (Beerman
et al., 2010; Challen et al., 2010; Copley et al., 2012). A recent
study using a single-cell barcode technology also demonstrated
the highly heterogeneous nature of the LMPP population (Naik
et al., 2013). To add to the complexity, we have now shown
that ST-HSCs and MPPs contain heterogeneous subsets based
on their cytokine secretion profile. It is reasonable to speculate
that the skewed cytokine production ability of ST-HSCs and
MPPs may also reflect a biased lineage potential. Unfortunately,
the current chip design does not allow us to recover the various
cell subsets on the basis of their cytokine secretion profile for
functional and lineage potential analysis. The possible relation-
ship between the heterogeneous cytokine production ability
and their lineage potential and functional capacity represents a
future direction for research.
Regulation of HSPC Cytokine Production by NF-kB
NF-kB is a family of transcription factors central to the regulation
of inflammation and immune cell activation. Almost three de-448 Cell Stem Cell 14, 445–459, April 3, 2014 ª2014 Elsevier Inc.cades of research has elucidated many key physiological func-
tions of NF-kB in innate and adaptive immune cells as well as
its involvement in the pathogenesis of many immunological dis-
eases (Baltimore, 2011). However, much less is known about the
physiological function of NF-kB in HSPCs during inflammation.
Because both LPS and Pam3CSK4 can activate NF-kB, which
in turn can upregulate the transcription of many inflammatory
cytokines in mature immune cells, we suspected that NF-kB
might also regulate cytokine production in HSPCs. To test this,
we first determined whether the important components of
the TLR/NF-kB pathway were expressed at the protein level in
HSPCs. Using a transgenic mouse that has a knockin of a
RELA-GFP fusion protein at the endogenous locus (De Lorenzi
et al., 2009), we found that all LT-HSCs and LSK cells were
GFP+, indicating that all HSPCs express RELA (also known
as p65) protein, a key subunit of NF-kB (Figure 3A). Then, we
showed that both TLR-2 and TLR-4 receptors were expressed
on the surface of LSK cells, and a subset of them express both
receptors (Figure 3B), a finding consistent with previous reports
(Nagai et al., 2006). Next, we asked whether HSPCs have func-
tional NF-kBactivity upon TLR stimulation. To study this, we took
advantage of a different transgenic NF-kB-GFP reporter mouse,
one with GFP expression under the control of the NF-kB regula-
tory elements (Magness et al., 2004). LPS stimulation in vivo
upregulated GFP expression from 8% basally to 35%–40% in
both LSK cells and LT-HSCs (Figures 3C and 3D). More directly,
when purified LSK cells and LT-HSCs were stimulated with LPS
and Pam3CSK4 in vitro, NF-kB activation was again evident by
both the percent of GFP+ cells and mean fluorescence intensity
(Figures 3E and 3F). These results demonstrate that both LSK
cells and LT-HSCs contain functional TLR/NF-kB signaling that
can be directly activated by TLR-4 and TLR-2 ligands.
To determine whether NF-kB regulates cytokine production in
LSK cells, we took advantage of mice deleted for genes impor-
tant to the NF-kB pathway. NFKB1 (also known as p50) is one
of the main subunits of the NF-kB family of transcription factors,
and p50 deficiency results in defective NF-kB activity in various
immune cells (Sha et al., 1995). In contrast, miR-146a is an
important negative regulator of NF-kB activation by targeting
its upstream signaling transducers TRAF6 and IRAK1. Thus,
deficiency in miR-146a leads to enhanced NF-kB activity (Boldin
et al., 2011; Zhao et al., 2011, 2013). When we subjected LSK
cells from Nfkb1/ mice (p50 knockout [KO]) and Mir146a/
mice (miR KO) to the single-cell chip analysis, we found that pro-
duction of all 12 cytokines was significantly attenuated in p50 KO
LSK cells and enhanced in miR KO LSK cells in comparison to
wild-type (WT) LSK cells (Figures 4A–4C and S3). Although
37.9% ofWT LSK cells produced cytokines under costimulation,
the percentage rose to an impressive 69.7% in miR KO and
dropped to a mere 2.4% in p50 KO LSK cells (Figure 4A).
Furthermore, the percentage of cytokine-producing LSK cells
in Mir146a/ Nfkb1/ (miR/p50 double knockout [DKO]) mice
was less than in WT mice, indicating that the lack of p50 is
dominant over miR-146a deficiency (Figures 4A–4C and S3). In
addition to the percentage of responding cells, the amount of
cytokines produced on a per-cell basis was also enhanced in
miR KO LSK cells and reduced in p50 LSK cells for all the proin-
flammatory cytokines (Figure 4B). These data demonstrate that
cytokine production in LSK cells is regulated by the level of
Figure 2. Single-Cell Analysis of Cytokine Production by Various HSPC Subsets in Response to TLR Stimulation
(A–E) Data from single-cell cytokine chip analysis. The six cell groups analyzed are BM (total BM cells), LSK cells, LMPPs (LSK CD34+Flt3hi), MPPs (LSK
CD34+Flt3int), ST-HSCs (LSK CD34+Flt3), and LT-HSCs (LSK CD34Flt3), all under LPS and Pam3CSK4 stimulation for 12 hr.
(A) Polyfunctionality and population-level statistics of the cell types analyzed. The percentage of cells secreting different number of cytokines is shown for each
cell type studied. Different colors represent cells producing different number of cytokines from 1 to 12 (labeled with different colors); the number on top of each
cell type represents the total percentage of cells secreting detectable amount of any of the 12 cytokines.
(B) Comparison of HSPC subsets by individual cytokines. Four out of 12 cytokines are shown here, and the rest are shown in Figure S4B. Each plot is composed
of several thousand individual dots from several thousand single cells. The six cell groups arranged from left to right are total BM, LSK cells, LMPPs, MPPs,
ST-HSCs, and LT-HSCs under LPS and Pam3CSK4 stimulation. The numbers on top represent the percentage of cytokine-producing cells identified by the gate
(the dotted line), and the bars represent the mean intensity of only the cytokine-producing cells (average intensity of the cells above the dotted line).
(C) A summary heat map showing the percentage of the six groups of cells that secrete any individual cytokine under different stimulations.
(D and E) Principal component analysis of all six cell groups that reduce a 12-dimensional cytokine data set from six different cell groups into two principal
components (PC1 and PC2).
(D) PC1 represents the overall cytokine production capacity of a cell and is positively correlated to the overall intensity of all 12 cytokines (see Figure S4C). After all
12 cytokine intensities of each cell are converted into a single PC1 value, the relative frequency of cells with each PC1 value is calculated for all six cell subsets.
Graphs show the relative frequency of cells (y axis) of the six cell groups against PC1 (x axis). Each cell type is represented by a different color.
(E) PC2 represents the level of biased cytokine production profile and is positively correlated to the lymphoid group of cytokines, including IL-2, IL-17a, IL-4, IL-12,
IL-1b, and IFN-g, but is negatively correlated to the myeloid group of cytokines, including TNF-a, IL-6, and GM-CSF (see Figures S4D and S4E). Graphs show the
relative frequency of cells (y axis) of the six cell groups against PC2 (x axis). Each cell type is represented by a different color.
See also Figure S4.
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Figure 3. NF-kB Activation through TLRs in HSPCs
(A–F) Data from FACS analysis.
(A) Representative FACS histogram of LSK cells (blue) and HSCs (LSK CD150+CD48; red) from RELA-GFP transgenic mice. LSK cells from a WT C57Bl/6 mice
were used as a negative control (black).
(B) Representative FACS plots of TLR-2 and TLR-4 surface expression of WT LSK cells. Blue represents isotype antibody control, and red represents fluo-
rescence-conjugated antibodies against TLR-2 (left), TLR-4 (middle), or both (right).
(C–F) Determination of TLR and NF-kB functionality in LSK cells and HSCs with mice in which GFP production is under NF-kB regulatory control.
(C and D) Experiments from in vivo stimulation.
(C) LPS-stimulated WT mouse is used as a negative control (top row) for GFP expression. No stimulation (middle row) corresponds to PBS-treated NF-kB-GFP
transgenic reporter mice. LPS stimulation (bottom row) corresponds to LPS-stimulated NF-kB-GFP transgenic reporter mice (2 mg/kg body weight LPS for 6 hr).
(D) Quantification of GFP+ percentages in LSK cells and HSCs from negative control, unstimulated, and LPS-stimulated NF-kB-GFP transgenic reporter
mice (n = 3).
(E and F) Experiments from in vitro stimulation of purified LSK cells and HSCs.
(legend continued on next page)
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HSPCs Regulate Myelopoiesis via CytokinesNF-kB activity. Tuning the NF-kB activity up or down is sufficient
to increase or decrease the cytokine production of LSK cells in
response to TLR stimulation. We also measured the coproduc-
tion of any two cytokines at the single-cell level (Figures 4D
and 4E). Correlation coefficients (R values) were calculated for
all cytokine pairs for WT, p50 KO, and miR KO LSK cells, higher
R values indicating tighter coregulation. In general, WT LSK cells
showed higher correlation coefficients than either p50 KO ormiR
KO LSK cells, indicating a better coregulation of these cytokines
(Figure 4E, green blocks). This may be functionally important,
given that many of these cytokines are often produced together
by a single cell; e.g., myeloid cells produce TNF-a, IL-6, and IL-
12 during an inflammatory response, and CD4 TH1 cells produce
IL-2 and IFN-g. Imbalance in cytokine levels could lead to unde-
sired effects and pathologies. When we performed a principal
component analysis on LSK cells of all genotypes, a myeloid
cytokine group including IL-6, TNF-a, IL-1b, and GM-CSF and
a lymphoid cytokine group including IL-2, IL-4, and IL-17a
were again identified (Figure 4F). Plotting the measurements
onto the dominant 2D principal component space revealed
diminished production of both groups of cytokines in p50 KO
LSK cells and enhanced production in miR KO LSK cells. Inter-
estingly, enhancement in the myeloid component was even
more prominent in miR KO LSK cells, suggesting miR-146a-defi-
cient LSK cells have especially enhanced myeloid cytokine
production. Overall, these results demonstrate that TLR-stimula-
tion-mediated cytokine production in HSPCs is exquisitely
regulated by the level of NF-kB activity.
Functional Significance of HSPC-Produced Cytokines in
Regulating Myelopoiesis In Vitro
Cytokines produced by HSPCs are also produced by mature
immune cells in the BM and periphery. However, we hypothesize
that the location of HSPCs in the stem cell niche may represent
an inherent advantage, allowing HSPC-produced cytokines to
efficiently regulate their own fate in a more timely fashion during
an infection or inflammatory challenge. To assess the functional
significance of HSPC-produced cytokines, we first compared
the cytokine production capacity of LSK cells with that of more
differentiated progenitor cells and mature immune cells. To
this end, purified LSK cells and lineage-committed progenitor
cells (LincKit+Sca1 and LincKitSca1+) from BM as well as
CD11b+myeloid, CD4+ T, CD8+ T, and B220+ B cells from spleen
were stimulated with LPS plus Pam3CSK4 for 24 hr. Then,
culture medium was collected for multiplexed ELISA in order to
measure a panel of 15 cytokines. Surprisingly, in the absence
of survival and proliferative advantage after stimulation (Fig-
ure S5A), LSK cells produced far more cytokines in both quantity
and breadth thanmaturemyeloid and lymphoid cells in 24 hr with
LPS and Pam3CSK4 stimulation. More impressively, even with
much stronger stimuli, such as CpG, anti-CD3 and anti-CD28,
or 100-fold more LPS, T, B, and myeloid cells were still signifi-
cantly less potent cytokine producers than LSK cells (Figure 5A).
In addition, LSK cells produced a wide range of myeloid and(E) Representative FACS histograms of LSK cells and HSCs sorted from NF-kB-G
and red represents cells stimulated in vitro with LPS (100 ng/ml) for 6 hr.
(F) Quantification of GFP+ percentages andGFPmean fluorescence intensity of LS
mean ± SEM.lymphoid cytokines, whereas mature myeloid cells and lympho-
cytes showed narrower cytokine production profile.
Next, we determined whether the cytokines produced by
HSPCs are able to influence hematopoiesis in vitro. First, we
showed that a fraction of LT-HSCs, LSK cells, and myeloid
progenitor cells expressed various cytokine receptors, including
IL-6Ra, IFN-gR, TNF-R1, and TNF-R2, on their surfaces (Fig-
ure S6A). This is consistent with previous studies that provided
direct and indirect evidence of cytokine receptor expression in
HSPCs (Baldridge et al., 2010, 2011; Maeda et al., 2009; Pronk
et al., 2011). Next, we measured myeloid differentiation of LSK
cells under LPS and Pam3CSK4 stimulation. Using an IL-6
neutralizing antibody, we were able to determine the effect of
taking away IL-6 produced by LSK cells on myelopoiesis (Fig-
ures 5B and 5C). Interestingly, in comparison to the isotype
antibody control, the neutralization of IL-6 had a significant effect
on myeloid differentiation. Specifically, the percent of CD11b+
cells produced from LSK cells decreased by about 50%, and
the number of CD11b+ cells showed a 2-fold reduction over a
4-day period (Figures 5B and 5C). To extend the study to
include several other abundantly produced cytokines, we found
that the neutralization of TNF-a or GM-CSF, but not IFN-g, also
had an inhibitory effect on the generation of myeloid cells (Fig-
ures 5D and 5E). Interestingly, neutralization of IL-6, IFN-g, or
GM-CSF all decreased the number of LSK cells, suggesting
that these cytokines produced by LSK cells have a positive
effect on their own proliferation and/or survival (Figure 5E). It is
worth noting that we have previously shown that IL-6 can directly
induce LSK cell proliferation by BrdU incorporation (Zhao et al.,
2013). To further demonstrate the functional importance of
HSPC-produced cytokines, we compared cytokines produced
by BM cells that were depleted of HSPCs to that of total BM
cells in inducing myelopoiesis. To this end, we stimulated
equal number of total BM cells and Sca1-depleted BM cells
with LPS and Pam3CSK4 in vitro for 24 hr and then used the
conditioned media to stimulate LSK cells. We saw up to 40%
reduction in the number CD11b+ myeloid cells after only
2 days of incubation with conditioned medium from Sca1-
depleted BM cells (Figure 5F). This suggests that HSPCs, ac-
counting for less than 1% of total BM cells, make a significant
contribution to the cytokine milieu and have a stimulatory
effect on myelopoiesis. Instead of depleting cytokine, we next
askedwhether increased cytokine production by LSK cells could
enhance myelopoiesis. To this end, we used miR-146a-deficient
LSK cells that showed exaggerated cytokine production (Fig-
ure 4). Purified LSK cells from WT or miR KO mice were stimu-
lated with LPS and Pam3CSK4 in vitro for 24 hr, and then
the conditioned media were used to stimulate newly purified
WT LSK cells. After 2 days, we saw a modest but consistent in-
crease in numbers of both LSK cells and CD11b+ cells when WT
LSK cells were cultured with miR KO-LSK-cell-conditioned
medium in comparison to WT-LSK-cell-conditioned medium
(Figure 5G). This suggests that with just 24 hr of cytokine accu-
mulation, the exaggerated cytokine production by miR KO LSKFP transgenic reporter mice. Blue represents unstimulated LSK cells or HSCs
K cells at 0, 4, 6, and 12 hr and HSCs at 0 and 6 hr (n = 3). Data are presented as
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Figure 4. Regulation of HSPC Cytokine Production by NF-kB
(A–F) Data from single-cell cytokine chip analysis. LSK cells were sorted from WT, Nfkb1/ (p50 KO),Mir146a/ (miR KO), and Nfkb1/Mir146a/ (miR/p50
DKO) mice and were stimulated with LPS and Pam3CSK4 for 12 hr.
(A) Polyfunctionality and population level statistics of LSK cells of different genetic models. The percentage of LSK cells secreting a different number of cytokines
is shown for each cell type studied. Different colors represent cells producing different number of cytokines from 1 to 12 (labeled by different colors); the number
on top of each cell type represents the total percentage of cells secreting detectable amount of any cytokine.
(legend continued on next page)
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HSPCs Regulate Myelopoiesis via Cytokinescells is sufficient to support enhancedmyelopoiesis and LSK cell
proliferation and/or survival. Consistent with this in vitro finding,
miR KO mice exhibit a significant myeloproliferative disease
after chronic inflammatory stimulation as a result of enhanced
HSPC proliferation and myeloid differentiation, whereas deleting
IL-6 in miR KO mice effectively ameliorates the myeloprolifera-
tive condition (Zhao et al., 2013). Complementing our previous
reports that have shown the involvement of hyperactivated
T cells and myeloid cells in miR-146a-deficiency-mediated
pathologies (Zhao et al., 2011, 2013), this study shows that
exaggerated cytokine production by miR-146a-deficient HSPCs
is also a contributor to enhanced myelopoiesis in miR-146a
KO mice.
Functional Significance of HSPC-Produced Cytokines in
Regulating Myelopoiesis In Vivo
In addition to in vitro functional significance, we next determined
whether HSPC-produced cytokines are important in regulating
hematopoiesis in vivo. Because current technology does not
allow us to delete a cytokine specifically and selectively in stem
and progenitor cells while allowing cytokine production inmature
cells, to overcome this hurdle, we have created leucopenic
conditions in vivo in which mature myeloid and lymphoid cells
are severely depleted, whereas stem and progenitor cells are
preserved. We created these conditions in mice by injecting a
chemotherapeutic drug, 5-flurouracil (5-FU) (Figures 6A–6C) or
by transplanting stem and progenitor cells after lethal irradiation
(Figures 6D–6F). LPS was injected into mice in order to stimulate
myelopoiesis when neutropenia became the most severe, as
measured by periodic sampling of peripheral blood. 5-FU is a
chemotherapeutic drug that induces a significant reduction in
mature cells in both BM and periphery while stimulating stem
and progenitor cells to cycle (Harrison and Lerner, 1991). After
5-FU injection, myeloid cells started to decline, and, by day 5,
80% of myeloid cells were depleted in WT, miR-146a KO, IL-6
KO, and miR-146a/IL-6 DKO mice (Figure 6A). At this time,
low-dose LPS was injected in order to stimulate myelopoiesis.
Consistent with in vitro studies, IL-6 KO mice showed a 2-fold
decrease in CD11b+ and Gr1+ myeloid cells, whereas miR KO
mice showed a modest increase in comparison to WT mice (Fig-
ures 6B and 6C). In addition, DKOmice showed a similar level of
reduction as IL-6 KOmice, indicating that loss of IL-6 is the domi-
nant factor. To perform stem cell transplant, 500,000 purified
LincKit+ cells from WT, miR KO, IL-6 KO, or miR/IL-6 DKO(B) Comparison of the cytokine secretion capacity of LSK cells from different ge
protein with the four different mouse models arranged from left to right (p50 KO, g
several thousand individual dots from several thousand single cells. The number
(the dotted line), and the bars represent the mean intensity of only the positive c
(C) A summary heat map showing the percentage of LSK cells that secrete any i
(D) 2D scatter plots showing protein pair correlations. Results from p50 KO (gree
(R value) of the two cytokines for the different mouse models are shown on the p
(E) A half matrix summarizing the comparison of correlation coefficients (R values
square block, intercepted by two cytokines with one on the top and one to the
represents the case when WT LSK has the highest correlation, such as IL-6 versu
such as IL-6 versus IFN-g. Correlations for all protein pairs from the p50 KO LSK
(F) Principal component analysis of LSK cells from the four genetic models. The
reduced space is the one that can explain the most (>60%) information of the dat
aligned to the x and y axes.
See also Figure S3.mice were injected into lethally irradiated WT recipient mice. All
four groups of mice showed severe leucopenia 6 days after irra-
diation and cell injection, and approximately 8,000 myeloid cells
and 20,000 total white blood cells were left in the peripheral
blood. This represented less than 1% of the normal level and
4% of the number of transplanted HSPCs (Figures 6D–6F). LPS
stimulation promoted myelopoiesis that was mildly increased in
mice receiving miR KO HSPCs but was significantly attenuated
in mice receiving IL-6 KO or miR/IL-6 DKO HSPCs, indicating
that IL-6 produced by HSPCs is an important factor in promoting
myeloid cell recovery during neutropenia (Figures 6D–6F).
Overall, these in vivo experiments show that, in mice with severe
leucopenia, LPS-stimulated production of cytokines, especially
IL-6, by endogenous or transplanted HSPCs has a significant
positive impact on stress-induced myelopoiesis.
Within the BM niche, we speculate that the cytokines released
by HSPCs upon TLR stimulation can act on themselves or neigh-
boring HSPCs. To further delineate whether HSPC-produced
cytokines mediate hematopoiesis predominantly through an
autocrine or paracrine fashion, we injected NF-kB-GFP reporter
mice with both LPS and BrdU in order to determine the relation-
ship between cytokine-producing HSPCs and proliferating
HSPCs. GFP expression, an indicator of NF-kB activation and
cytokine production, and BrdU incorporation, a marker of prolif-
eration, were costained in myeloid progenitor cells, LSK cells,
and LT-HSCs at 4, 12, and 24 hr (Figure 6G). The result showed
that LSK cells and LT-HSCs rapidly turned on NF-kB in response
to LPS stimulation, whereas myeloid progenitor cells went into
cycle quickly. As time elapsed, LT-HSCs and LSK cells started
to proliferate, whereas NF-kB activity gradually dampened.
Interestingly, throughout the stimulation, cells with NF-kB activ-
ity and cells that rapidly proliferated represented two largely
nonoverlapping populations in all the stem and progenitor sub-
sets. Although this result has multiple potential interpretations,
the fact that we have been unable to capture a large fraction
of cells that are simultaneously positive for BrdU and GFP
throughout the 24 hr interval suggests to us the following
mechanism: LPS-mediated NF-kB activation in HSPCs does
not appear to directly turn on a proliferation program, and,
instead, cytokines are induced that, in turn, act on cytokine re-
ceptors on neighboring HSPCs to stimulate proliferation and dif-
ferentiation. The nature of this type of paracrine signaling and the
distinction between the proliferative and the NF-kB-activated
subsets within HSPCs require further investigation.netic models. Each plot represents cytokine intensity scatter plots for a single
reen; miR/p50 DKO, yellow; WT, blue; miR KO, red). Each plot is composed of
s on top represent the percentage of cytokine-producing cells above the gate
ytokine-producing cells (average intensity of the cells above the dotted line).
ndividual cytokine.
n), WT (blue), and miR KO (red) LSK cells are plotted. Correlation coefficients
lots.
) of any given cytokine pairs betweenWT, p50 KO, and miR KO LSK cells. Each
right, represents correlation coefficients between the two cytokines. Green
s GM-CSF, and red represents when miR KO LSK has the highest correlation,
cells are always lower than either WT or miR KO.
data are plotted onto the 2D space by the top two principal components. This
a. The directions of the two protein groups are represented by the two vectors
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Figure 5. In Vitro Analysis of Functional Significance of HSPC-Produced Cytokines
(A) Multiplexed ELISA quantification of cytokines in bulk cell-culture medium in order to compare cytokine production of different FACS-purified cell subsets
stimulated for 24 hr with various stimulations. Cell types include LSK cells, LSK+ (LinSca1cKit+), and LS+K (LinSca1+cKit) sorted fromBMs and CD4+ T,
CD8+ T, CD19+ B, and CD11b+ myeloid cells sorted from spleens. Stimulations include LPS/Pam (100 ng/ml LPS and 1 mg/ml Pam3CSK4), LPS/Pam/stem cell
(legend continued on next page)
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In this study, we have shown that ST-HSCs andMPPs can trans-
late danger signals arising from an infection into cytokine signals
that can directly regulate stress-induced hematopoiesis. Signif-
icantly, the cytokine production ability of HSPCs trumps both
mature myeloid and lymphoid cells in terms of speed, magni-
tude, and breadth. In the BM stem cell niche, this property of
HSPCs may play an important role in providing a rapid response
time from the encounter of an infection to the output of myeloid
cells. In addition to residing in the BM, HSPCs are known
to egress from the marrow and traffic through the blood and
lymphatic circulation to peripheral organs, including spleen,
liver, lymph nodes, gut, and adipose tissues, where they may
be exposed to a heavy burden of danger signals. These extrame-
dullary sites may provide excellent opportunities for HSPCs to
coordinate rapid stress-induced hematopoiesis upon TLR stim-
ulation (Han et al., 2010; Jaiswal andWeissman, 2009;Massberg
et al., 2007; Wesemann et al., 2013).
Given that all the cytokines produced by HSPCs are also pro-
duced by mature immune cells and some nonhematopoietic
cells, isolating the effect of cytokines produced by HSPCs
from mature cells in vivo is difficult, if not impossible, given cur-
rent technical limitations in specifically deleting a gene in HSCs
while turning it back on in mature cells. Therefore, we have relied
on in vitro studies to demonstrate the functional importance of
HSPC-produced cytokines in regulating myelopoiesis. In addi-
tion, there are situations when mature immune cells are signifi-
cantly depleted, such as during sepsis, after chemotherapy,
and during the initial recovering phase of stem cell transplant.
During these situations, when mature immune cells are depleted
and HSPCs are overrepresented, the ability of HSPCs to
respond to stress directly in order to produce cytokines may
become critical in mediating rapid hematopoietic cell recovery.
We have created these situations in mice to mimic neutropenic
conditions after chemotherapy or stem cell transplant and
have shown that the ability of HSPCs to produce IL-6 is particu-
larly important in mediating stress-induced myelopoiesis. In clin-
ical practice, G-CSF and GM-CSF are used in certain situations
after chemotherapy or stem cell transplant to stimulate neutro-
phil recovery in neutropenic patients who are susceptible to fatal
infections (Bennett et al., 2013). A better understanding of the
cytokine-mediated hematopoiesis in neutropenic conditionsfactor (SCF; 100 ng/ml LPS, 1 mg/ml Pam3CSK4, and 50 ng/ml SCF), CpG (1 mM),
medium; BM, culture medium from unstimulated total BM cells. Data are presente
represented in white, and high level represented in red. Cytokines are clustered
(B–E) Analysis of in vitro myelopoiesis from WT LSK cells by FACS. Sorted WT L
(50 ng/ml) in the presence of cytokine-neutralizing antibodies. Control, isotype ant
anti-TNF-a neutralizing antibodies.
(B and C) Time course of myelopoiesis from WT LSK cells in the presence of ant
(D and E) Myelopoiesis from WT LSK cells in the presence of various neutralizing
myeloid cells and LSK cells. The representative FACS plots (B and D); quantifica
(F and G) FACS analysis of in vitro myelopoiesis from WT LSK cells in the presen
(F) WT total BM cells or WT BM cells depleted of Sca1+ cells were stimulated wit
culturingmedium. Then, the culturingmediumwas used to stimulate freshly purifie
(G) WT or miR-146a KO LSK cells were stimulated with LPS and Pam3CSK4 for 2
culturing mediumwas used to stimulate freshly purifiedWT LSK cells. The numbe
mean ± SEM.
See also Figure S5.will provide insight in the development of potentially more effec-
tive hematopoietic stimulating factors.
In addition to neutropenic conditions, we reason that this stem
and progenitor cell property is also important under physiolog-
ical conditions, despite of the rarity of HSPCs among differenti-
ated hematopoietic cells. First, the speed, magnitude, and
breadth of the cytokines produced by HSPCs in comparison to
mature immune cells are impressive. Furthermore, this has not
taken into the account the unique location of HSPCs in the
stem cell niche. Location and organization of HSPCs within the
BM niche have long been appreciated to play an important role
in their self-renewal and proliferative properties (Shen and Nils-
son, 2012). Perhaps groups of HSPCs residing in close proximity
represent a unique advantage for rapid autocrine or paracrine-
mediated hematopoiesis. Through BrdU incorporation in NF-
kB-GFP reporter mice, we have shown that HSPCs with NF-kB
activity and that are actively proliferating are largely two distinct
populations. We speculate that a potential paracrine regulatory
signaling may be at work within the BM that involves one subset
of HSPCs responding to TLR stimulation by rapidly turning on
NF-kB and producing copious amounts of cytokines and a
neighboring cell population with cytokine receptors that can un-
dergo rapid proliferation and differentiation in response to cyto-
kine stimulation. In support of the notion, although some LSK
cells express both TLR-4 and IL-6Ra, it appears that a fraction
of LSK cells express only the TLR or the cytokine receptor (Fig-
ure S6B), suggesting that HSPCs contain heterogeneous sub-
sets with intrinsic differences in their ability to respond to TLR
and cytokine stimuli.
The questions regarding the extent of involvement of HSPC-
produced cytokines in hematopoiesis in a nonneutropenic host
and the nature of HSPC heterogeneity on the basis of differential
cytokine production or receptor expression remain open and will
be an area of significant interest for future studies. In addition, we
are also currently redesigning the microfluidic platform in order
to recover individual cells from the chip after proteomic analysis
for subsequent lineage and functional analysis. Furthermore,
there are perhaps limitations in the in vitro on-chip stimulation,
which may not provide the optimal conditions for culturing undif-
ferentiated HSPCs. This may result in a reduction in the cells’
functional robustness and an underestimate of the true percent-
age of cytokine-producing cells in vivo, despite our poststimula-
tion analysis to ensure that HSPCs remain phenotypicallyLPS (10 mg/ml), CD3/28 (1 mg/ml anti-CD3 and 1 mg/ml anti-CD28). Blank, fresh
d as a heat map with low cytokine level represented in blue, intermediate level
into groups.
SK cells were stimulated with LPS (100 ng/ml), Pam3CSK4 (1 mg/ml), and SCF
ibody control; all Abs, a combination of anti-IL-6, anti-IFN-g, anti-GM-CSF, and
i-IL-6 neutralizing antibody.
antibodies. Cells were analyzed on day 3 by FACS for percent and number of
tion (n = 3; C and E).
ce of conditioned medium.
h LPS and Pam3CSK4 for 24 hr in order to induce cytokine production into the
dWT LSK cells. Number ofmyeloid and LSK cells was analyzed on day 2 (n = 8).
4 hr in order to induce cytokine production into the culturing medium. Then, the
r of myeloid and LSK cells was analyzed on day 2 (n = 3). Data are presented as
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Figure 6. In Vivo Analysis of Functional Significance of HSPC-Produced Cytokines
(A–C) For 5-FU-induced neutropenia, WT, miR-146a KO, IL-6 KO, and miR-146a/IL-6 DKO mice were injected with 5-FU (250 mg/kg of body weight, i.p.).
(A) Peripheral blood was analyzed on days 0, 2, 4, and 5 by FACS in order to determine the number of CD11b+ myeloid cells. On day 5, LPS (0.3 mg/kg
of body weight, i.p.) was injected, and mice were bled 24 hr later in order to study LPS-induced myelopoiesis by analyzing the number of CD11b+ (B) or Gr1+
(C) cells.
(legend continued on next page)
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Cell Stem Cell
HSPCs Regulate Myelopoiesis via Cytokinesundifferentiated by FACS and morphologically intact by micro-
scopy. The ability to recover individual cells poststimulation will
allow us to better assess cell viability.
Functions of NF-kB in immune cells have been extensively
studied. However, knowledge of the functional role of NF-kB in
HSPCs has been limited. In this study, we have connected a
known function of NF-kB, the regulation of cytokine production,
to two unexpected multipotent hematopoietic cell populations,
ST-HSCs and MPPs. What is also intriguing is that some
LT-HSCs appear able to respond to TLR stimulation by the acti-
vation of NF-kB, and all HSCs appear to have at least the p65
subunit of NF-kB. Thus, despite NF-kB by itself being insufficient
to enable cytokine secretion in LT-HSCs, NF-kB is present from
the inception of hematopoiesis and may regulate other aspects
of HSC biology.
EXPERIMENTAL PROCEDURES
Animal Models
All mice (WT, Nfkb1/, Mir146a/, Il6/, Nfkb1/Mir146a/, Il6/
Mir146a/, RELA-GFP knockin, and NF-kB-eGFP reporter mice) were on a
C57BL/6 genetic background and housed under a specific pathogen-free con-
dition at the California Institute of Technology. Mice used for all experiments
were age- and sex-matched 6- to 8-week-old female mice. All experiments
were approved by the institutional Animal Care and Use Committee of the
California Institute of Technology.
FACS Sort
In general, 15 to 20 mice of the same genotype were used for FACS sorting in
order to obtain sufficient stem and progenitor cells. First, BM cells were sub-
jected to magnetic bead selection (Miltenyi Biotec) according to manufac-
turer’s protocol in order to deplete lineage-positive cells, and then they were
sorted on a BD FACSAria sorter at the California Institute of Technology
FACS Core. More details can be found in the Supplemental Experimental
Procedures.
Single-Cell Cytokine Chip Analysis
We integrated upstream FACS purification techniques with the single-cell
barcode chip in order to study the functional proteomics from phenotypically
defined single cells. The chips used in this study have > 5,000 microchambers
of about 100 picoliter volume to enable sensitive detection of proteins. Within
each microchamber, a panel of 12 cytokines (TNF-a, GM-CSF, IL-6, IL-12p40,
IFN-g, IL-2, IL-4, IL-10, TGF-b1, CCL-2, IL-17A, and IL-1b) can be simulta-
neously measured by sandwich ELISA-like assay. Themanufacture procedure
of the chip has been described in our previous study (Ma et al., 2011), and the
detailed experimental steps can be found in the Supplemental Experimental
Procedures. In brief, FACS-purified cells were cultured at 37C in 5% CO2
cell incubator with medium alone, medium plus LPS, or medium plus LPS
and Pam3CSK4 for 12 hr. At the end of stimulation, the chip was imaged
with a high-resolution bright-field microscope. Cell number in each chamber
was counted, and cell viability was assessed to exclude fragmented or non-
light-reflective cells by trained personnel in a blind manner. Then, cells were
washed off, and the chips were developed via an immuno-sandwich assay.
A GenePix 4400A microarray scanner was used to scan slides, and data
were analyzed with GenePix Pro 7. Each single-cell chip analysis of a
specific cell subset, genotype, and stimulating condition was performed at
least two times.(D–F) For stem cell transplant studies, LincKit+ cells were purified from the BM o
mouse were injected intravenously into lethally irradiated WT recipient mice. On
neutropenia. LPS was injected (0.3 mg/kg of body weight, i.p.), and, 48 hr later,
number of total white blood cells (D), CD11b+ cells (E), and Gr1+ cells (F).
(G) LPS (2 mg/kg of body weight, i.p.) and BrdU (1 mg, i.p.) were injected into NF-k
12, and 24 hr. Representative FACS plots of GFP expression and BrdU incorporat
See also Figure S6.Mutliplexed Cytokine Analysis of Bulk Cell-Culture Medium
For multiplexed cytokine analysis of bulk cell-culture medium, 100,000 cells of
each FACS-purified subset were stimulated in 100 ml medium with various
stimulations for 24 hr in a 96-well plate. Then, the medium was collected
and concentrated by 4-fold before being subjected to multiplexed ELISA
quantification of 15 different cytokines and chemokines. For multiplexed
ELISA quantification, the detection method was identical to the single-cell
chip analysis described above. The difference is that the sample here consists
of culturing medium only. In brief, the ELISA chip was first blocked with 3%
BSA in PBS buffer and then hybridized with an antibody-single-stranded
DNA conjugate cocktail and washed with 3% BSA in PBS followed by the
application of a medium sample. The assay was completed by applying sec-
ondary biotinylated antibodies and streptavidin-cy3 in sequence. Multiplexed
cytokine analysis of a specific cell subset, genotype, and stimulating condition
was performed at least two times.
In Vitro Analysis of Myeloid Differentiation
For analysis of myeloid differentiation under cytokine-neutralizing antibodies,
sorted LSK cells (15,000 cells per 100 ml medium) were stimulated with LPS
(100 ng/ml), Pam3CSK4 (1 mg/ml), and stem cell factor (50 ng/ml) in the pres-
ence of various cytokine-neutralizing antibodies. Antibody concentrations
used were isotype control (1 mg/ml), anti-iFN-g (1 mg/ml), anti-iL-6 (1 mg/ml),
anti-GM-CSF (5 mg/ml), and anti-TNF-a (5 mg/ml; eBioscience). Cells were
analyzed on day 3 by FACS for the percent and number of myeloid cells and
LSK cells. For the analysis of myeloid differentiation under conditioned
medium, WT or miR-146a KO LSK cells (30,000 cells per 100 ml medium)
were stimulated with LPS (100 ng/ml) and Pam3CSK4 (1 mg/ml) for 24 hr in
order to induce cytokine production into the culturing medium. Then, the
culturing medium from either WT or miR KO LSK cells was collected and
used to stimulate freshly purified WT LSK cells. The number of myeloid and
LSK cells was analyzed after 2 days by FACS. All experiments were performed
two times with three biological replicates, each of which was sorted from
pooled BM cells of six to ten mice.
In Vivo Analysis of Myeloid Differentiation
For 5-FU-induced leucopenia, WT, miR-146a KO, IL-6 KO, and miR-146a/IL-6
DKO mice were injected with 5-FU (250 mg/kg of body weight, intraperitone-
ally [i.p.] injected; Sigma-Aldrich). Peripheral blood was obtained on days 0, 2,
4, and 5 for FACS analysis in order to determine the severity of neutropenia. On
day 5, LPS (0.3 mg/kg of body weight, i.p.) was injected, and mice were bled
24 hr later for FACS analysis. For stem cell transplant study after lethal irradi-
ation, LincKit+ cells were purified from the BM of WT, miR-146a KO, IL-6 KO,
and miR-146a/IL-6 DKO mice. 500,000 cells were injected intravenously into
each lethally irradiated (1,000 rad in one dose) WT recipient mice. On day 6,
mice were bled for FACS analysis and LPS injection (0.3 mg/kg of bodyweight,
i.p.) was given; 48 hr later, mice were bled again for FACS analysis. Data
represent cumulative results from two independent mouse experiments.
Computational Algorithm and Statistical Analysis
In Figures 3 and 5, F tests were used to compare variances, and then the
appropriate two-sided Student’s t tests were applied. All figures with error
bars were graphed as mean ± SEM. For all heat maps, scale bars represent
mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001.
For all single-cell cytokine chip analysis, custom-written software routines
in R languagewere used to process, analyze, and visualize the single-cell func-
tional assay results. In brief, the algorithm converts raw fluorescence images
into numerical fluorescence intensity values for each assayed protein within
a given microchamber matched with the number of cells. The number of
cells within each microchamber was determined manually by microscopy.f WT, miR-146a KO, IL-6 KO, and miR-146a/IL-6 DKO mice. 500,000 cells per
day 6, mice were bled for FACS analysis in order to determine the degree of
mice were bled in order to study LPS-induced myelopoiesis by analyzing the
B-GFP transgenic reporter mice, which were harvested for FACS analysis at 4,
ion of LSK+ cells, LSK cells, and HSCs. Data are presented as mean ± SEM.
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Cell Stem Cell
HSPCs Regulate Myelopoiesis via CytokinesThe average background signal levels from all zero-cell microchambers were
used to set the gate in order to separate nonproducing cells from cytokine-pro-
ducing cells. Detailed statistical analysismethod for principal component anal-
ysis (Figures 1D, 2D, 2F, and 4F) can be found in the Supplemental Experi-
mental Procedures and our previous publication (Ma et al., 2011). These
types of statistical analysis and graphical representations are routinely used
to analyze large-scale multidimensional data sets from numerous cell subsets
(Bendall et al., 2011).SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.stem.2014.01.007.
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